Fact CheckerSign in

NCT06408610Completed

Moderate Continuous Versus High Interval Intensity Training on Gut Dysbiosis and GLP1 Hormone in IBS

Moderate Continuous Versus High Interval Intensity Training on Gut Dysbiosis and Glucagon Like Peptide Hormone in Irritable Bowel Syndrome

Source: ClinicalTrials.gov · Last updated 11 Jun 2025

Brief summary (registry, in English)

investigating the response of gut bacteria via measuring short chain fatty acids and Glucagon like peptide hormone to two different modes of exercises in pre-diabetic, obese patients with irritable bowel syndrome. It will be hypothesized that there will be no significant difference between the moderate continuous versus high interval intensity training on gut dysbiosis and glucagon like peptide hormone in irritable bowel syndrome.

Status (registry)
Completed
Study type
Interventional
Enrollment
66 (actual)
First submitted
7 May 2024
Start date
May 2024
Primary completion date
May 2025
Lead sponsor
Cairo University
Diseases
Obesity
NCT number
NCT06408610

What you commit to

  • Study type: Interventional
  • Participants enrolled: 66
  • From May 2024 to the primary completion date, May 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Communication disorders
  • Gasterointestinal bleeding
  • Colorectal cancer or any terminal diseases
  • Cardiovascular diseases
  • Upper respiratory infections
  • Uncontrolled hypertension

Other

  • Antibiotics or probiotics in the last 2 months
  • Recent surgeries in the last 6 months
  • Fibromylgia or Multiple sclerosis
  • Palpable abdominal mass
  • Active smokers
  • Musculoskeletal injuries that interfere with exercise program

Who the study is looking for

  • Body mass index must be 30-34.9 kg\\m
  • Clinical diagnosis of irritable bowel syndrome
  • Must be Pre-diabetic HbA1c of 5.7 - 6.4.
  • Must be sedentary subject

Age in the registry: 20 years to 45 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Medicine Cairo University
Coordinator of this site? Confirm its status
CairoEgyptUnknown status
Faculty of physiotherapy cairo university
Coordinator of this site? Confirm its status
GizaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.